EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Decreased homovanillic acid and 5‐hydroxyindoleacetic acid levels in the cerebrospinal fluid of patients with Dravet syndrome with parkinsonism

Ryo Sugiyama iD, Takashi Saito iD, Atsuko Katsumoto, Shota Yoneno, Tomoyuki Akiyama, Hirofumi Komaki

Epilepsia Open · 2025

DOI: 10.1002/epi4.70034 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Epilepsia Open, 2025. Verfasst von Ryo Sugiyama und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan. Hauptthemen laut MEDLINE: Epilepsies, Myoclonic, Homovanillic Acid, Hydroxyindoleacetic Acid, Parkinsonian Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JSPS Grants-in-Aid for Scientific Research, MHLW Research program on rare and intractable diseases, The Intramural Reseach Grant for Neurological and Psychiatric Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dravet syndrome (DS) is an early onset, developmental, and epileptic encephalopathy characterized by drug‐resistant seizures and multiple comorbidities. It has been reported that in adulthood, it may be accompanied by parkinsonism, but the pathogenesis of this condition remains unclear. We performed dopamine transporter single‐photon emission computed tomography (DAT SPECT) and measured monoamine metabolite levels in the cerebrospinal fluid (CSF) in two adult patients with DS who developed parkinsonism around the age of 30 years. DAT SPECT showed no abnormalities in either patient, whereas CSF tests revealed significant decreases in the levels of homovanillic and 5‐hydroxyindoleacetic acids. One patient with severe symptoms was treated with levodopa–carbidopa, which improved parkinsonism manifestations. The other patient initiated treatment with a low dose and has been continuing the treatment without any reported side effects. In conclusion, CSF testing can detect a decrease in dopamine synthesis and may be useful in monitoring the efficacy of levodopa treatment in patients with DS and parkinsonism. Plain Language Summary Dravet syndrome (DS) is an early onset, developmental, and epileptic encephalopathy. DS can lead to the development of parkinsonism in adulthood, a clinical syndrome characterized by tremor, slowed movements, and rigidity. Although parkinsonism is a significant issue for patients, its underlying pathology has not yet been elucidated. In this study, we confirmed that the levels of monoamine metabolites in the CSF were low in two patients, potentially shedding light on the pathology involved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsies, MyoclonicHomovanillic AcidHydroxyindoleacetic AcidParkinsonian DisordersAdultHumansCarbidopaLevodopaTomography, Emission-Computed, Single-PhotonDrug Combinations

Stichwörter der Autor:innen

dopamine transporterlevodopamonoamine metabolitessingle‐photon emission computed tomography

Substanzen

Carbidopacarbidopa, levodopa drug combinationHomovanillic AcidHydroxyindoleacetic AcidLevodopaDrug Combinations

Autor:innen und Institutionen

  • Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
  • Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
  • Department of Pediatric Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Okayama, Japan.
  • Translational Medical Center, National Center of Neurology and Psychiatry, Kodaira, Japan.

ORCID-Profile: Ryo Sugiyama, Takashi Saito

Förderung

  • JSPS Grants-in-Aid for Scientific Research
  • MHLW Research program on rare and intractable diseases
  • The Intramural Reseach Grant for Neurological and Psychiatric Disorders

Zitieren

APA

Sugiyama, R., Saito, T., Katsumoto, A., Yoneno, S., Akiyama, T., & Komaki, H. (2025). Decreased homovanillic acid and 5‐hydroxyindoleacetic acid levels in the cerebrospinal fluid of patients with Dravet syndrome with parkinsonism. Epilepsia Open. https://doi.org/10.1002/epi4.70034

Vancouver

Sugiyama R, Saito T, Katsumoto A, Yoneno S, Akiyama T, Komaki H. Decreased homovanillic acid and 5‐hydroxyindoleacetic acid levels in the cerebrospinal fluid of patients with Dravet syndrome with parkinsonism. Epilepsia Open. 2025. doi:10.1002/epi4.70034

BibTeX
@article{Sugiyama2025,
  author = {Sugiyama, Ryo and Saito, Takashi and Katsumoto, Atsuko and Yoneno, Shota and Akiyama, Tomoyuki and Komaki, Hirofumi},
  title = {Decreased homovanillic acid and 5‐hydroxyindoleacetic acid levels in the cerebrospinal fluid of patients with Dravet syndrome with parkinsonism},
  journal = {Epilepsia Open},
  year = {2025},
  doi = {10.1002/epi4.70034}
}
Kostenlos starten →